Biostar Pharmaceuticals (BSPM) Swings to Q2 Profit

Biostar Pharmaceuticals (NASDAQ: BSPM) reported Q2 EPS of $0.11, versus ($0.06) reported last year. Revenue for the quarter came in at $19.2 million, versus $14.65 million reported last year.

For earnings history and earnings-related data on Biostar Pharmaceuticals (BSPM) click here.

You May Also Be Interested In

• Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
• Inter Parfums (IPAR) PT Lowered to $172 at Piper Sandler
• CEMEX, S.A.B. de C.V. (CX) Tops Q1 EPS by 5c